Alpha-keto carbonyl calpain inhibitors

Details for Australian Patent Application No. 2005276635 (hide)

Owner Santhera Pharmaceuticals (Schweiz) AG

Inventors Lescop, Cyrille; Hennebohle, Marco; Weyermann, Philipp; Siendt, Herve; Von Sprecher, Andreas; Herzner, Holger

Agent Shelston IP

Pub. Number AU-A-2005276635

PCT Pub. Number WO2006/021413

Priority 04020190.7 25.08.04 EP

Filing date 22 August 2005

Wipo publication date 2 March 2006

International Classifications

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07D 339/00 (2006.01) Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/021413 Priority application(s): WO2006/021413

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276640-2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as CRTH2 antagonists

2005276634-Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain